10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001638833-21-000146`
Period End Date	20210930
Filing Date	20211103
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	sgry-20210930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 101 Income Statement 124 Cash Flow Statement 82 Stockholders Equity 58 Comprehensive Income 24

Balance Sheet 101 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$254.00M	USD	Point-in-time
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$189.30M	USD	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$317.90M	USD	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	310,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$330.40M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$382.20M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$393.40M	USD	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	0.00	shares	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	310,000.00	shares	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	-	USD	Point-in-time
Inventories	`InventoryNet`	$56.40M	USD	Point-in-time
Inventories	`InventoryNet`	$59.30M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	$434.50M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$17.60M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$29.80M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$27.40M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$28.80M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$801.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$841.70M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $254.0 and $189.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$544.60M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $254.0 and $189.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$542.10M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.66B	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$3.51B	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$90.30M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$89.60M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$310.10M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$320.50M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	50.46M	shares	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	82.46M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$128.10M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	82.46M	shares	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$124.80M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$27.00M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$50.30M	USD	Point-in-time
Total assets	`Assets`	$5.63B	USD	Point-in-time
Total assets	`Assets`	$5.41B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$116.50M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$100.20M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$73.10M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$65.40M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$81.80M	USD	Point-in-time
Medicare accelerated payments and deferred governmental grants	`MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent`	$109.80M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$217.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$208.30M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$64.40M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$60.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$556.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$540.50M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.79B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.79B	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$300.90M	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$312.40M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$139.70M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$124.40M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$321.00M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$304.70M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$306.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$310.40M	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - $ and $434.5, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - $ and $434.5, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$434.50M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 82,458,385 and 50,461,706, respectively	`CommonStockValueOutstanding`	$500.00K	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 82,458,385 and 50,461,706, respectively	`CommonStockValueOutstanding`	$800.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$607.90M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.31B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-47.90M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-61.00M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-502.60M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-431.80M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$756.30M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$115.60M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$795.70M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$766.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$895.90M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$800.80M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.41B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.63B	USD	Point-in-time

Income Statement 124 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$496.10M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.31B	USD	3 Qtrs
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$559.20M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.61B	USD	3 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$398.20M	USD	3 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$468.70M	USD	3 Qtrs
Salaries and benefits	`LaborAndRelatedExpense`	$141.70M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$162.30M	USD	1 Quarter
Supplies	`SuppliesExpense`	$142.80M	USD	1 Quarter
Supplies	`SuppliesExpense`	$382.20M	USD	3 Qtrs
Supplies	`SuppliesExpense`	$464.90M	USD	3 Qtrs
Supplies	`SuppliesExpense`	$160.10M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$169.70M	USD	3 Qtrs
Professional and medical fees	`ProfessionalFees`	$46.30M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$56.80M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$138.40M	USD	3 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$23.40M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$21.90M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$68.80M	USD	3 Qtrs
Lease expense	`OperatingAndFinanceLeaseExpense`	$64.70M	USD	3 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$29.20M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$98.50M	USD	3 Qtrs
Other operating expenses	`OtherCostAndExpenseOperating`	$34.10M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$83.90M	USD	3 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$381.90M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$1.27B	USD	3 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$1.07B	USD	3 Qtrs
Cost of revenues	`OperatingCostsAndExpenses`	$436.70M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$25.50M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$76.80M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$25.20M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$73.30M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$69.30M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$76.10M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$24.10M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.20M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$3.10M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$8.50M	USD	3 Qtrs
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$7.60M	USD	3 Qtrs
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$2.90M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-700.00K	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-7.10M	USD	3 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.90M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-2.00M	USD	3 Qtrs
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$15.80M	USD	3 Qtrs
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$5.40M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$10.20M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$24.70M	USD	3 Qtrs
Impairment charges	`AssetImpairmentCharges`	-	USD	3 Qtrs
Impairment charges	`AssetImpairmentCharges`	$33.50M	USD	1 Quarter
Impairment charges	`AssetImpairmentCharges`	$33.50M	USD	3 Qtrs
Impairment charges	`AssetImpairmentCharges`	-	USD	1 Quarter
Grant funds	`GrantRevenue`	$-9.90M	USD	1 Quarter
Grant funds	`GrantRevenue`	$20.00M	USD	3 Qtrs
Grant funds	`GrantRevenue`	$33.20M	USD	3 Qtrs
Grant funds	`GrantRevenue`	-	USD	1 Quarter
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.10M	USD	3 Qtrs
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$500.00K	USD	1 Quarter
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Litigation settlement	`GainLossRelatedToLitigationSettlement`	$-1.20M	USD	3 Qtrs
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	3 Qtrs
Litigation settlement	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Other income	`OtherNonrecurringIncomeExpense`	$-1.70M	USD	3 Qtrs
Other income	`OtherNonrecurringIncomeExpense`	$-3.30M	USD	3 Qtrs
Other income	`OtherNonrecurringIncomeExpense`	$-500.00K	USD	1 Quarter
Other income	`OtherNonrecurringIncomeExpense`	-	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.43B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.23B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$495.60M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$477.60M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$18.50M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$187.40M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$63.60M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$86.70M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-147.80M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-51.50M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-160.90M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-54.20M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-33.00M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$9.40M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$26.50M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-61.10M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-1.30M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$1.20M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-14.50M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$1.30M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-46.60M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$8.20M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-34.30M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$27.80M	USD	3 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$27.30M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$98.60M	USD	3 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$75.00M	USD	3 Qtrs
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$31.10M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-22.90M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-61.60M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-70.80M	USD	3 Qtrs
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-121.60M	USD	3 Qtrs
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$10.30M	USD	3 Qtrs
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$10.00M	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	-	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$29.20M	USD	3 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-150.80M	USD	3 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-81.10M	USD	3 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-22.90M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-71.60M	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-1.46	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-3.09	USD	3 Qtrs
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.28	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-1.19	USD	3 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-1.46	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-1.19	USD	3 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-3.09	USD	3 Qtrs
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.28	USD	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	80.73M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.74M	shares	3 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.35M	shares	3 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.88M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	80.73M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.74M	shares	3 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.88M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.35M	shares	3 Qtrs

Cash Flow Statement 82 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-46.60M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$8.20M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-34.30M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$27.80M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$69.30M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$76.10M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$24.10M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.20M	USD	1 Quarter
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-12.00M	USD	3 Qtrs
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-3.10M	USD	3 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$3.00M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$9.90M	USD	3 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$13.40M	USD	3 Qtrs
Equity-based compensation expense	`ShareBasedCompensation`	$4.10M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-700.00K	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-7.10M	USD	3 Qtrs
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-1.90M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-2.00M	USD	3 Qtrs
Impairment charges	`AssetImpairmentCharges`	-	USD	3 Qtrs
Impairment charges	`AssetImpairmentCharges`	$33.50M	USD	1 Quarter
Impairment charges	`AssetImpairmentCharges`	$33.50M	USD	3 Qtrs
Impairment charges	`AssetImpairmentCharges`	-	USD	1 Quarter
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-9.10M	USD	3 Qtrs
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$500.00K	USD	1 Quarter
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-15.30M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-2.30M	USD	3 Qtrs
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-200.00K	USD	3 Qtrs
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$1.00M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$29.40M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$30.30M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$11.90M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$18.40M	USD	3 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$141.00M	USD	3 Qtrs
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-48.50M	USD	3 Qtrs
DOJ settlement payments	`IncreaseDecreaseInSettlementPayments`	$32.20M	USD	3 Qtrs
DOJ settlement payments	`IncreaseDecreaseInSettlementPayments`	-	USD	3 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-19.50M	USD	3 Qtrs
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$2.10M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$67.40M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$238.00M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$27.80M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$43.50M	USD	3 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$14.20M	USD	3 Qtrs
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$101.00M	USD	3 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$48.30M	USD	3 Qtrs
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$2.50M	USD	3 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-500.00K	USD	3 Qtrs
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-300.00K	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-141.70M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$6.80M	USD	3 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$197.30M	USD	3 Qtrs
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$328.40M	USD	3 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$293.00M	USD	3 Qtrs
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$428.00M	USD	3 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$8.30M	USD	3 Qtrs
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$11.70M	USD	3 Qtrs
Proceeds from equity offering	`ProceedsFromIssuanceOfCommonStock`	$260.90M	USD	3 Qtrs
Proceeds from equity offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	3 Qtrs
Payments of equity offering costs	`PaymentsOfStockIssuanceCosts`	$12.70M	USD	3 Qtrs
Payment of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	-	USD	3 Qtrs
Payment of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$5.10M	USD	3 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$97.50M	USD	3 Qtrs
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$82.30M	USD	3 Qtrs
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromMinorityShareholders`	$2.40M	USD	3 Qtrs
Receipts (payments) related to ownership transactions with non-controlling interest holders	`PaymentsToMinorityShareholders`	$27.30M	USD	3 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-14.40M	USD	3 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-300.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$86.50M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$112.50M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$357.30M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$12.20M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$450.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$330.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$450.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$93.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$318.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$330.40M	USD	Point-in-time

Stockholders Equity 58 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	82.46M	shares	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$895.90M	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$800.80M	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-9.70M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-13.90M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$100.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-4.90M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-42.30M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-1.20M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.80M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.80M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.00M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$-2.80M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.70M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.10M	USD	1 Quarter
Preferred share conversion	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$439.70M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$10.30M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$9.70M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$9.50M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$10.00M	USD	1 Quarter
Equity offering	`StockIssuedDuringPeriodValueNewIssues`	$248.30M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$7.30M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.40M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$200.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$13.10M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.50M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$3.30M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-25.20M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-14.60M	USD	3 Qtrs
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$37.10M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$-30.30M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$700.00K	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$2.30M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$1.70M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$5.60M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$21.80M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$22.30M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$18.80M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$20.80M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$14.90M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$20.90M	USD	1 Quarter
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	50.46M	shares	Point-in-time
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	82.46M	shares	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.53B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.55B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$983.40M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$882.10M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$923.40M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.11B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$895.90M	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$800.80M	USD	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-46.60M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$8.20M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-34.30M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$27.80M	USD	3 Qtrs
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$7.30M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.40M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$200.00K	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$13.10M	USD	3 Qtrs
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.50M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$3.30M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-25.20M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-14.60M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-31.00M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-61.20M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$14.70M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$40.90M	USD	3 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$98.60M	USD	3 Qtrs
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$27.30M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$31.10M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$75.00M	USD	3 Qtrs
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-58.30M	USD	1 Quarter
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-16.40M	USD	1 Quarter
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-57.70M	USD	3 Qtrs
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-136.20M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.